Variety of treatments The administration has sought to buy a variety of FDA-authorized therapeutics to ensure a mix of effective treatments, part of what the administration is calling its “medicine cabinet," the officials said.
They asked not to be identified because the two antiviral pills are not yet authorized by regulators. The Food and Drug Administration earlier this month authorized AstraZeneca Plc’s Evusheld, a pre-exposure prevention treatment for the immunocompromised and other people who respond poorly to vaccines.
The administration believes that all data so far suggests it works against omicron, the officials said. The administration also expects to allocate about another 300,000 courses of GlaxoSmithKline Plc’s monoclonal